vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.

NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $31.5M, roughly 1.1× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs 5.1%, a 3.0% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -4.6%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (7.0% CAGR vs -0.2%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

CHCT vs NRC — Head-to-Head

Bigger by revenue
NRC
NRC
1.1× larger
NRC
$35.2M
$31.5M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+9.5% gap
CHCT
4.8%
-4.6%
NRC
Higher net margin
CHCT
CHCT
3.0% more per $
CHCT
8.1%
5.1%
NRC
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
7.0%
-0.2%
NRC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CHCT
CHCT
NRC
NRC
Revenue
$31.5M
$35.2M
Net Profit
$2.5M
$1.8M
Gross Margin
Operating Margin
13.3%
Net Margin
8.1%
5.1%
Revenue YoY
4.8%
-4.6%
Net Profit YoY
60.2%
-72.6%
EPS (diluted)
$49.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
NRC
NRC
Q1 26
$31.5M
Q4 25
$30.9M
$35.2M
Q3 25
$31.1M
$34.6M
Q2 25
$29.1M
$34.0M
Q1 25
$30.1M
$33.6M
Q4 24
$29.3M
$36.9M
Q3 24
$29.6M
$35.8M
Q2 24
$27.5M
$35.0M
Net Profit
CHCT
CHCT
NRC
NRC
Q1 26
$2.5M
Q4 25
$14.4M
$1.8M
Q3 25
$1.6M
$4.1M
Q2 25
$-12.6M
$-106.0K
Q1 25
$1.6M
$5.8M
Q4 24
$1.8M
$6.6M
Q3 24
$1.7M
$5.7M
Q2 24
$-10.4M
$6.2M
Operating Margin
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
13.3%
Q3 25
22.4%
Q2 25
4.7%
Q1 25
25.6%
Q4 24
26.0%
Q3 24
22.3%
Q2 24
25.3%
Net Margin
CHCT
CHCT
NRC
NRC
Q1 26
8.1%
Q4 25
46.6%
5.1%
Q3 25
5.3%
11.9%
Q2 25
-43.2%
-0.3%
Q1 25
5.3%
17.2%
Q4 24
6.3%
17.8%
Q3 24
5.9%
15.9%
Q2 24
-37.9%
17.6%
EPS (diluted)
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
$0.52
$49.58
Q3 25
$0.03
$0.18
Q2 25
$-0.50
$-0.01
Q1 25
$0.03
$0.25
Q4 24
$0.04
$0.27
Q3 24
$0.04
$0.24
Q2 24
$-0.42
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
NRC
NRC
Cash + ST InvestmentsLiquidity on hand
$2.6M
$4.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$421.3M
$14.0M
Total Assets
$1.0B
$134.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
NRC
NRC
Q1 26
$2.6M
Q4 25
$3.3M
$4.1M
Q3 25
$3.4M
$2.2M
Q2 25
$4.9M
$5.3M
Q1 25
$2.3M
$2.5M
Q4 24
$4.4M
$4.2M
Q3 24
$2.8M
$3.5M
Q2 24
$734.0K
$485.0K
Total Debt
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
$48.7M
Q2 24
$457.6M
$33.3M
Stockholders' Equity
CHCT
CHCT
NRC
NRC
Q1 26
$421.3M
Q4 25
$429.4M
$14.0M
Q3 25
$426.8M
$14.3M
Q2 25
$437.8M
$21.3M
Q1 25
$461.3M
$29.7M
Q4 24
$476.0M
$31.3M
Q3 24
$477.2M
$34.6M
Q2 24
$497.8M
$40.2M
Total Assets
CHCT
CHCT
NRC
NRC
Q1 26
$1.0B
Q4 25
$990.8M
$134.9M
Q3 25
$987.3M
$135.7M
Q2 25
$966.3M
$141.4M
Q1 25
$985.1M
$135.2M
Q4 24
$992.6M
$132.5M
Q3 24
$981.8M
$131.8M
Q2 24
$983.2M
$119.1M
Debt / Equity
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
1.41×
Q2 24
0.92×
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
NRC
NRC
Operating Cash FlowLast quarter
$7.2M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
17.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
$56.4M
$7.2M
Q3 25
$12.7M
$13.8M
Q2 25
$13.8M
$-1.1M
Q1 25
$14.4M
$6.6M
Q4 24
$58.9M
$6.4M
Q3 24
$13.8M
$9.4M
Q2 24
$16.7M
$6.8M
Free Cash Flow
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
$35.9M
$6.1M
Q3 25
$7.6M
$10.2M
Q2 25
$9.6M
$-4.1M
Q1 25
$9.7M
$3.7M
Q4 24
$34.2M
$1.9M
Q3 24
$6.7M
$7.8M
Q2 24
$9.5M
$1.5M
FCF Margin
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
116.0%
17.2%
Q3 25
24.6%
29.4%
Q2 25
32.9%
-12.2%
Q1 25
32.3%
10.9%
Q4 24
116.9%
5.2%
Q3 24
22.5%
21.8%
Q2 24
34.7%
4.3%
Capex Intensity
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
66.3%
3.2%
Q3 25
16.3%
10.4%
Q2 25
14.5%
8.8%
Q1 25
15.6%
8.9%
Q4 24
84.1%
12.0%
Q3 24
24.2%
4.5%
Q2 24
26.1%
15.0%
Cash Conversion
CHCT
CHCT
NRC
NRC
Q1 26
Q4 25
3.91×
3.99×
Q3 25
7.76×
3.34×
Q2 25
Q1 25
9.06×
1.15×
Q4 24
32.14×
0.97×
Q3 24
7.92×
1.66×
Q2 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons